Targeting protein ubiquitination for drug discovery. What is in the drug discovery toolbox?

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Drug Discovery Today

• Publication date

  2001-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1359-6446(00)01650-0PMID 11182597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A role for ubiquitin ligase recruitment in retrovirus release.

  2000cited by this paper
• Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

  2000cited by this paper
• Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein

  2000cited by this paper
• Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells

  2000cited by this paper
• Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2.

  2000cited by this paper
• Pharmacological proteasome inhibitors and their therapeutic potential

  2000cited by this paper
• The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases.

  2000cited by this paper
• Ubiquitin and its kin: how close are the family ties?

  2000cited by this paper
• Quantitative expression analysis of the cellular specificity of HECT-domain ubiquitin E3 ligases.

  2000cited by this paper
• Development of screening systems for drugs against human papillomavirus-associated cervical cancer: based on E6-E6AP binding.

  2000cited by this paper
• Regulation of transcription factors by protein degradation

  2000cited by this paper
• Ubiquitin-like proteins: new wines in new bottles.

  2000cited by this paper
• Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.

  2000cited by this paper
• A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination.

  2000cited by this paper
• Harnessing the ubiquitination machinery to target the degradation of specific cellular proteins.

  2000cited by this paper
• Insights into SCF ubiquitin ligases from the structure of the Skp1–Skp2 complex

  2000cited by this paper
• Ubiquitin/Proteasome Pathway Regulates Levels of Retinoic Acid Receptor γ and Retinoid X Receptor α in Human Keratinocytes

  2000cited by this paper
• Proteasome inhibitors: from in vitro uses to clinical trials

  2000cited by this paper
• Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome.

  2000cited by this paper
• Development of a Ubiquitin Transfer Assay for High Throughput Screening by Fluorescence Resonance Energy Transfer

  2000cited by this paper
• Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.

  2000cited by this paper
• Role of the proteasome in Alzheimer's disease.

  2000cited by this paper
• Nonhydrolyzable diubiquitin analogues are inhibitors of ubiquitin conjugation and deconjugation.

  2000cited by this paper
• Ubiquitin is part of the retrovirus budding machinery.

  2000cited by this paper
• The ubiquitin system

  2000cited by this paper
• The measurement of ubiquitin and ubiquitinated proteins

  1999cited by this paper
• Conjugation of the ubiquitin-like protein NEDD8 to cullin-2 is linked to von Hippel-Lindau tumor suppressor function.

  1999cited by this paper
• Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade.

  1999cited by this paper
• Down-regulation of types I, II and III inositol 1,4,5-trisphosphate receptors is mediated by the ubiquitin/proteasome pathway.

  1999cited by this paper
• The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.

  1999cited by this paper
• Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels.

  1999cited by this paper
• The F-box: a new motif for ubiquitin dependent proteolysis in cell cycle regulation and signal transduction.

  1999cited by this paper
• SCF and Cullin/Ring H2-based ubiquitin ligases.

  1999cited by this paper
• 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.

  1999cited by this paper
• Application of homogeneous time-resolved fluorescence (HTRFTM) to monitor poly-ubiquitination of wild-type p53.

  1999cited by this paper
• Implication of proteasome in estrogen receptor degradation

  1999cited by this paper
• Ubiquitin-mediated degradation of active Src tyrosine kinase.

  1999cited by this paper
• The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro

  1999cited by this paper
• A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation

  1999cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Deubiquitinating enzymes: a new class of biological regulators.

  1998cited by this paper
• Lactacystin, Proteasome Function, and Cell Fate*

  1998cited by this paper
• Characterization of Human hect Domain Family Members and Their Interaction with UbcH5 and UbcH7*

  1998cited by this paper
• Ubiquitin and the control of protein fate in the secretory and endocytic pathways.

  1998cited by this paper
• Preproparathyroid Hormone-related Protein, a Secreted Peptide, Is a Substrate for the Ubiquitin Proteolytic System*

  1997cited by this paper
• Growth Hormone-induced Signal Transduction Depends on an Intact Ubiquitin System*

  1997cited by this paper
• Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome

  1997cited by this paper
• The ubiquitin-mediated proteolytic pathway as a therapeutic area

  1997cited by this paper
• Targeting of substrates to the 26S proteasome

  1997cited by this paper
• Inhibition of NF‐κB cellular function via specific targeting of the IκB‐ubiquitin ligase

  1997cited by this paper
• Pathways of ubiquitin conjugation

  1997cited by this paper
• Regulation of ubiquitin‐dependent processes by deubiquitinating enzymes

  1997cited by this paper
• Roles of ubiquitin-mediated proteolysis in cell cycle control.

  1997cited by this paper
• Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase.

  1997cited by this paper
• Crystal structure of a pair of follistatin‐like and EF‐hand calcium‐binding domains in BM‐40

  1997cited by this paper
• De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome

  1997cited by this paper
• Role of the ubiquitin/proteasome system in regulated protein degradation in Saccharomyces cerevisiae.

  1996cited by this paper
• Ubiquitinylation and Ubiquitin-dependent Proteolysis in Vertebrate Photoreceptors (Rod Outer Segments)

  1996cited by this paper
• Ubiquitination of protein kinase C-alpha and degradation by the proteasome.

  1996cited by this paper
• UBE3A/E6-AP mutations cause Angelman syndrome

  1996cited by this paper
• WW domains of Nedd4 bind to the proline‐rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome.

  1996cited by this paper
• Huntingtin Is Ubiquitinated and Interacts with a Specific Ubiquitin-conjugating Enzyme*

  1996cited by this paper
• SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.

  1996cited by this paper
• Ubiquitination of Protein Kinase C-α and Degradation by the Proteasome*

  1996cited by this paper
• Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade

  1995cited by this paper
• Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.

  1995cited by this paper
• Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation.

  1995cited by this paper
• Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.

  1994cited by this paper
• A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1.

  1988cited by this paper
• Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85.

  1984cited by this paper

• UbiNet 2.0: a verified, classified, annotated and updated database of E3 ubiquitin ligase–substrate interactions

  2021cites this paper
• Enantioselective Synthesis of Natural Epoxyquinoids

  2013cites this paper
• USE OF TRANSITION METAL–CATALYZED CASCADE REACTIONS IN NATURAL PRODUCT SYNTHESIS AND DRUG DISCOVERY

  2013cites this paper
• Application of a tandem metathesis to the synthesis of (+)-panepophenanthrin.

  2010cites this paper
• The JAMM motif of human deubiquitinase Poh1 is essential for cell viability

  2007cites this paper
• Chemistry of Epoxyquinols A, B, and C and Epoxytwinol A

  2007cites this paper
• Total synthesis of the epoxyquinol dimer (+)-panepophenanthrin: application of a diastereospecific biomimetic Diels–Alder dimerisation

  2006cites this paper
• Enantio- and diastereoselective total synthesis of (+)-panepophenanthrin, a ubiquitin-activating enzyme inhibitor, and biological properties of its new derivatives.

  2006cites this paper
• Enantioselective total synthesis of (+)-Panepophenanthrin, a novel inhibitor of the Ubiquitin-activating enzyme

  2004cites this paper
• UBP 41 Is a Proapoptotic Ubiquitin-specific Protease 1

  2003cites this paper
• Total synthesis of panepophenanthrin.

  2003cites this paper
• Total synthesis of the ubiquitin-activating enzyme inhibitor (+)-panepophenanthrin.

  2003cites this paper
• UBP41 is a proapoptotic ubiquitin-specific protease.

  2003cites this paper
• Panepophenanthrin, from a mushroom strain, a novel inhibitor of the ubiquitin-activating enzyme.

  2002cites this paper